Delivery Order SPE2DB22D2009-SPE2DB25FL9BH
Award Date
5/2/25
Potential Completion Date
5/5/25
Potential Value
$16K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $14,581.38, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Ozempic, a diabetes medication, with an ultimate completion date of April 23, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
This federal contract award, valued at $2,409.64, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order (SPE2DB25FMPQZ) that provides the DLA with Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a diabetes medication. The contract is not set aside and has a performance period through April 30, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (SPE2DX) with the...
This federal contract award, valued at $13,176.28, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a medication used to treat diabetes. The contract is a firm fixed-price agreement with an ultimate completion date of April 21, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,122.93, is for the delivery of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a diabetes medication. This is a firm fixed-price delivery order with a performance period ending on May 1, 2025. The contract is not set-aside and was awarded on April 30, 2025. Amerisourcebergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,188.27 firm-fixed-price delivery order is for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a diabetes medication. The contract has an ultimate completion date of December 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, SPE2DB20D3505|SPE2DB25FT5X0, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,358.97 delivery order contract is for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a diabetes medication. The contract has a firm fixed price pricing type and an ultimate completion date of December 12, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award, valued at $3,759.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of Ozempic 0.25-0.5 mg/dose pens, a diabetes treatment medication. The contract has a firm fixed price and an ultimate completion date of May 5, 2025. Amerisourcebergen Drug Corp is the prime contractor, and the contract is not designated as a set-aside. The company holds a...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for $2,177.06 and covers the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a diabetes medication. The contract is a Firm Fixed Price Delivery Order with a completion date of January 9, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,651.91 firm fixed-price delivery order is for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a diabetes medication. The contract has a period of performance through October 21, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ozempic, a diabetes medication. The contract, valued at $11,208.44, is a Firm Fixed Price Delivery Order with a performance period through January 14, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as...